This trial is being conducted to assess the safety and effectiveness of VOLITE XC, an injectable gel, for the improvement of horizontal neck lines.
2 Primary · 3 Secondary · Reporting Duration: Up to 10 Months
Experimental Treatment
212 Total Participants · 1 Treatment Group
Primary Treatment: VOLITE XC · No Placebo Group · Phase 3
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:New York | 57.1% |
Louisiana | 14.3% |
California | 14.3% |
Other | 14.3% |
18 - 65 | 100.0% |
Cosmetic Laser Dermatology /ID# 239121 | 16.7% |
Delricht Research /ID# 242001 | 16.7% |
Skin And Aesthetics Surgery Of Manhattan /ID# 243607 | 50.0% |
Other | 16.7% |
Met criteria | 85.7% |
Did not meet criteria | 14.3% |